Infectious and inflammatory stimuli decrease endothelial nitric oxide synthase activity in vitro

Journal of Hypertension

Volumn 21, Issue 11, 2003, Pages 2103-2110

  Cardaropoli, Simona ^a   Silvagno, Francesca ^a   Morra, Emanuella ^a   Pescarmona, Gian Piero ^a   Todros, Tullia ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Endothelium; Infection; Iron; Nitric oxide synthase

Indexed keywords

ANTIHYPERTENSIVE AGENT; DEFEROXAMINE; DIMER; FERRITIN; HEME; IRON; LIPOPOLYSACCHARIDE; MESSENGER RNA; MONOMER; NITRIC OXIDE SYNTHASE; SUCCINYLACETONE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENDOTHELIUM; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INCUBATION TIME; INFECTION; INFLAMMATION; IRON DEPLETION; IRON METABOLISM; LOW TEMPERATURE PROCEDURES; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; STIMULATION;

EID: 1542300211     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200311000-00020     Document Type: Article

References (48)

1. Williams MJ, Poultron R, Williams S. Relationship of serum ferritin with cardiovascular risk factors and inflammation in young men and women. Atherosclerosis 2002; 165:179-184.
2. Konijn AM, Carmel N, Levy R, Hershko C. Ferritin synthesis in inflammation. II. Mechanism of increased ferritin synthesis. Br J Haematol 1981; 49:361-370.
3. Tran TN, Eubanks SK, Schaffer KJ, Zhou CYJ, Linder MC. Secretion of ferritin by rat hepatoma cells and its regulation by inflammatory cytokines and iron. Blood 1997; 90:4979-4986.
4. Tilg H, Ulmer H, Kaser A, Weiss G. Role of IL-10 for induction of anemia during inflammation. J Immunol 2002; 169:2204-2209.
5. Stam TC, Swaak AJ, Kruit WH, Eggermont AM. Regulation of ferritin: a specific role for interferon-alpha (INF-alpha)? The acute phase response in patients treated with IFN-alpha-2b. Eur J Clin Invest 2002; 32:79-83.
6. Ramsey PS, Andrews WW, Goldenberg RL, Tamura T, Wenstrom DK, Johnston KE, et al. Elevated amniotic fluid ferritin levels are associated with inflammation-related pregnancy loss following mid-trimester amniocentesis. J Matern Fetal Neonatal Med 2002; 11:302-306.
7. Lopez-Jaramillo P, Casas JP. Serrano N. Preeclampsia: from epidemiological observations to molecular mechanisms. Braz J Med Biol Res 2001; 34:1227-1235.
8. Trogstad LI, Eskild A, Bruu AL, Jeansson S, Jenum PA. Is preeclampsia an infectious disease? Acta Obstet Gynecol Scand 2001; 80: 1036-1038.
9. Dadelszen P Von, Magee LA. Could an infectious trigger explain the differential maternal response to the shared placental pathology of preeclampsia and normotensive intrauterine growth restriction? Acta Obstet Gynecol Scand 2002; 81:642-648.
10. Vince GS, Starkey PM, Austgulen R, Kwiatkowski D, Redman CW. Interleukin-6, tumour necrosis factor and soluble tumour necrosis factor receptors in women with preeclampsia. Br J Obstet Gynaecol 1995; 102:20-25.
11. Teran E, Escudero C, Moya W, Flores M, Vallance P, Lopez-Jaramillo P. Elevated C-reactive protein and pro-inflammatory cytokines in Andean women with preeclampsia. Int J Gynaecol Obstet 2001; 75:243-249.
12. Rayman MP, Barlis J, Evans RW, Redman CW, King LJ. Abnormal iron parameters in the pregnancy syndrome preeclampsia. Am J Obstet Gynecol 2002; 187:412-418.
13. Todros T, Pescarmona GP. Cau MA. Preeclampsia: a state of iron deficiency? J Soc Gynecol Invest 2000; 7:150A.
14. Piperno A, Trombini P, Gelosa M, Mauri V, Pecci V, Vergani A, et al. Increased serum ferritin is common in men with essential hypertension. J Hypertens 2002; 20:1513-1518.
15. Kletzmayr J, Horl WH. Iron overload and cardiovascular complications in dialysis patients. Nephrol Dial Transplant 2002; 17:25-29.
16. Kalantar-Zadeh K, Don BR, Rodriguez RA, Humphreys MH. Serum ferritin is a marker of morbidity and mortality in hemodialysis patients. Am J Kidney Dis 2001; 37:564-572.
17. Hughes K, Choo M, Kuperan P, Ong CN, Aw TC. Cardiovascular risk factors in non-insulin-dependent diabetes compared to non-diabetic controls: a population-based survey among Asians in Singapore. Atherosclerosis 1998; 136:25-31.
18. Mendler MH, Turlin B, Moirand R, Jouanolle AM, Sapey T, Guayader D, et al. Insulin resistance-associated hepatic iron overload. Gastroenterology 1999; 117:1155-1163.
19. Raman L, Pawashe AB, Yasodhara P. Hyperferritinemia in pregnancy induced hypertension and eclampsia. J Postgrad Med 1992; 38:65-67.
20. Silacci P, Formentin K, Bouzourene K, Daniel F, Brunner HR, Hayoz D. Unidirectional and oscillatory shear stress differentially modulate NOS III gene expression. Nitric Oxide 2000; 4:47-56.
21. Choi JW, Im MW, Pai SH. Nitric oxide production increases during normal pregnancy and decreases in preeclampsia. Ann Clin Lab Sci 2002; 32:257-263.
22. Seligman SP, Buyon JP, Clancy RM, Young BK, Abramson SB. The role of nitric oxide in the pathogenesis of preeclampsia. Am J Obstet Gynecol 1996; 171:944-948.
23. Venema RC, Ju H, Zou R, Ryan JW, Venema VJ. Subunit interactions of endothelial nitric-oxide synthase. J Biol Chem 1997; 272:1276-1282.
24. Albrecht EWJA, Stegeman CA, Heeringa P, Henning RH, Goor H van. Protective role of endothelial nitric oxide synthase. J Pathol 2003; 199: 8-17.
25. Martina V, Bruno GA, Brancaleoni V, Zumpano E, Tagliabue M, Fornengo R, et al. Calcium blood level modulates endogenous nitric oxide action: effects of parathyroidectomy in patients with hyperparathyroidism. J Endocrinol 1998; 156:231-235.
26. Forstermann U, Boissel JP, Kleinert H. Expressional control of the 'constitutive' isoforms of nitric oxide synthase (NOS I and NOS III). FASEB J 1998; 12:773-790.
27. Panza JA. Endothelial dysfunction in essential hypertension. Clin Cardiol 1997; 33:II-26-II-33.
28. Huang PL. Mouse models of nitric oxide synthase deficiency. J Am Soc Nephrol 2000; 16:S120-S123.
29. Shesely EG, Maeda N, Kim HS, Desai KM, Krege JH, Laubach VE, et al. Elevated blood pressures in mice lacking endothelial nitric oxide synthase. Prac Natl Acad Sci USA 1996; 93:13176-13181.
30. Olson GL, Saade GR, Buhimschi I, Chwalisz K, Garfield RE. The effect of an endothelin antagonist on blood pressure in a rat model of preeclampsia. Am J Obstet Gynecol 1999; 181:638-641.
31. Wright SD, Detmers PA, Aida Y, Adamowski R, Anderson DC, Chad Z, et al. CD18-deficient cells respond to lipopolysaccharide in vitro. J Immunol 1990; 144:2566-2571.
32. Dandona P, Nix D, Wilson MF, Aljada A, Love J, Assicot M, Bohuon C. Procalcitonin increase after endotoxin injection in normal subjects. J Clin Endocrinol Metab 1994; 79:1605-1608.
33. Bussolino F, Wang JM, Defilippi P, Turrini F, Sanavio F, Edgell CJ, et al. Granulocyte-and granulocyte-macrophage-colony stimulating factors induce human endothelial cells to migrate and proliferate. Nature 1989; 337:471-473.
34. Silvagno F, Xia H, Bredt DS. Neuronal nitric-oxide synthase-mu, an alternatively spliced isoform expressed in differentiated skeletal muscle. J Biol Chem 1996; 271:11204-11208.
35. Di Fulvio M, Lincoln TM, Lauf PK. Ad ragna NC. Protein kinase G regulates potassium chloride cotransporter-3 expression in primary cultures of rat vascular smooth muscle cells. J Biol Chem 2001; 276:21046-21052.
36. Weinberg ED. Iron, infection, and neoplasia. Clin Physiol Biochem 1986; 4:50-60.
37. Eskeland B, Baerheim A, Ulvik R, Hunskaar S. Influence of mild infections on iron status parameters in women of reproductive age. Scan J Prim Health Care 2002; 20:50-56.
38. Ioannou GN, Tung BY, Kowdley KV. Iron in hepatitis C: villain or innocent bystander? Semin Gastrointest Dis 2002; 13:95-108.
39. Pugliese A, Gennero L, Pescarmona GP, Beccattini M, Morra E, Orofino G, Torre D. Serum citrate levels, haptoglobin haplotypes and transferrin receptor (CD71) in patients with HIV-1 infection. Infection 2002; 30: 86-89.
40. Node K, Kitakaze M, Yoshikawa H, Kosaka H, Hori M. Reduced plasma concentration of nitrogen oxide in individuals with essential hypertension. Hypertension 1997; 30:405-408.
41. Panza JA, Casino PR. Kilcoyne CM, Quyyumi AA. Role of endothelium-derived nitric oxide in the abnormal endothelium-dependent vascular relaxation of patients with essential hypertension. Circulation 1993; 87:1468-1474.
42. Chen K, Inoue M, Wasa M, Fukuzawa M, Kamata S, Okada A. Expression of endothelial constitutive nitric oxide synthase mRNA in gastrointestinal mucosa and its down-regulation by endotoxin. Life Sci 1997; 61: 1323-1329.
43. Yoshizumi M, Perrella MA, Burnett JC, Lee ME. Tumor necrosis factor downregulates an endothelial nitric oxide synthase messenger RNA by shortening its half-life. Circ Res 1993; 73:205-209.
44. Fahmy M, Young SP. Modulation of iron metabolism in monocyte cell line U937 by inflammatory cytokines: changes in transferrin uptake, iron handling and ferritin mRNA. Biochem J 1993; 296:175-181.
45. Denk A, Goebeler M, Schmid S, Berberich I, Ritz O, Lindemann D, et al. Activation of NF-kappa B via the Ikappa B kinase complex is both essential and sufficient for proinflammatory gene expression in primary endothelial cells. J Biol Chem 2001; 276:28451-28458.
46. Hanada T, Yoshimura A. Regulation of cytokine signaling and inflammation. Cytokine Growth Factor Rev 2002; 13:413-421.
47. Bove K, Neumann P, Gertzberg N, Johnson A. Role of eNOS-derived NO in mediating TNF-induces endothelial barrier dysfunction. Am J Physiol Lung Cell Mol Physiol 2001; 280:L914-L922.
48. Aljada A, Ghanim G, Assian E, Dandona P. Tumor necrosis factor-alpha inhibits insulin-induced increase in endothelial nitric oxide synthase and reduces insulin receptor content and phosphorylation in human aortic endothelial cells. Metabolism 2002; 51:487-491.